Stockscreener 앱 받기
7.12
4.56%
-0.34
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | 0.01 | 0.004 |
Operating Expenses
|
73.85%
1.317
|
5.036 | 1.828 | 2.187 | 3.648 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
73.85%
-1.317
|
-5.036 | -1.828 | -2.177 | -3.644 |
| Net Interest Income/Expense |
66.67%
0.002
|
0.006 | - | - | - |
| Nonoperating Income/Loss |
99.98%
0.001
|
4.955 | -0.03 | 0.01 | -0.025 |
| Income/Loss From Continuing Operations Before Tax |
1,525%
-1.316
|
-0.081 | -1.858 | -2.167 | -3.669 |
| Income Tax Expense/Benefit |
0.002
|
- | 1.194 | -0.21 | -0.412 |
| Income/Loss From Continuing Operations After Tax |
1,527%
-1.318
|
-0.081 | -3.052 | -1.957 | -3.257 |
|
Net Income/Loss
|
1,527%
-1.318
|
-0.081 | -3.052 | -1.957 | -3.257 |
| Preferred Stock Dividends And Other Adjustments |
0.02
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
-0.98
|
- | - | - | - |
| Diluted Earnings Per Share |
-0.98
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.02
|
- | - | - | - |
1.40%
자본화:
|
볼륨(24시간):